Am J Transplant, Volume 22, Suppl 3 Archives - Page 165 of 190 - ATC Abstracts

2022 American Transplant Congress
Identifying Health System-Level Barriers to Living Donor Kidney Transplantation: A Cross-Sectional Survey of Health Professionals
S. Sandal¹, I. Schiller¹, N. Dendukuri¹, J. Robert¹, K. Katergi¹, A. Alam¹, M. Cantarovich¹, J. F. Fiore Jr¹, C. Weber¹, M. Fortin²
¹McGill University, Montreal, QC, Canada, ²University of Montreal, Montreal, QC, Canada
*Purpose: There is growing recognition that efforts to increase living donor kidney transplantation (LDKT) should focus on health system-level inefficiencies. While previous studies focused on…
2022 American Transplant Congress
Cold Pulsatile Perfusion of Donor Kidneys Varies Significantly by Procuring Organ Procurement Organization Indicating Both Over and Underutilization of This Preservation Method
D. S. Keith, E. Lessmann
Kidney Transplant, Ascension Sacred Heart Hospital, Pensacola, FL
*Purpose: To assess the usage and variability cold pulsatile perfusion preservation in the United States based on procuring organ procurement organization (OPO).*Methods: All donors procured…
2022 American Transplant Congress
Faster B Cell Rebound is Observed Following Xenotransplantation Compared to Allotransplantation in a Highly Sensitized Nonhuman Primate Kidney Transplantation Model
I. DeLaura, M. Manook, D. Olaso, J. Yoon, R. Baldi, S. Knechtle, J. Kwun
Surgery, Duke Transplant Center, Durham, NC
*Purpose: Xenotransplantation outcomes have been greatly improved due to the advent of genetically engineered pigs and agents targeting the CD40-CD40L signaling pathway. However, studies have…
2022 American Transplant Congress
Utilization of a Pharmacy Technician to Improve Immunization Rates for Pediatric Heart and Kidney Transplant Recipients
A. Brewer¹, E. Benefield¹, S. Boehme¹, B. Jensen¹, K. Molina², C. Peterson², C. Heyrend¹
¹Primary Children's Hospital, Salt Lake City, UT, ²University of Utah, Salt Lake City, UT
*Purpose: Transplant recipients are at increased risk of infectious complications from vaccine-preventable diseases. This study aimed to evaluate using a pharmacy technician to provide routine…
2022 American Transplant Congress
Distinct Phenotypes of Kidney Transplant Recipients with Delayed Graft Function Identified Through Machine Learning Consensus Clustering
C. Jadlowiec¹, C. Thongprayoon², N. Leeaphorn³, W. Kaewput⁴, P. Pattharanitima⁵, M. Cooper⁶, W. Cheungpasitporn²
¹Division of Transplant Surgery, Mayo Clinic Arizona, Phoenix, AZ, ²Division of Nephrology and Hypertension, Mayo Clinic Rochester, Rochester, MN, ³Renal Transplant Program, University of Missouri-Kansas City School of Medicine/Saint Luke's Health System, Kansas City, MO, ⁴Department of Military and Community Medicine, Phramongkutklao College of Medicine, Bangkok, Thailand, ⁵Department of Internal Medicine, Thammasat University, Pathum Thani, Thailand, ⁶Medstar Georgetown Transplant Institute, Georgetown University School of Medicine, Washington, DC
*Purpose: The significance of delayed graft function (DGF) and its impact on kidney transplant (KT) outcomes remains debated. We aimed to assess outcomes for KT…
2022 American Transplant Congress
Does Comprehensive Geriatric Assessment Impact Risk Assessment for Potential Kidney Transplant Patients?
J. Patel¹, S. Hussain², D. Mills¹, A. Edobor³, E. Walters³, J. Williams³, Y. Kyeso², J. F. Fung³, R. Barth³, D. Rubin⁴, M. Huisingh-Scheetz², M. Martinchek⁵, M. L. Madariaga³
¹Pritzker School of Medicine, University of Chicago, Chicago, IL, ²Medicine, University of Chicago Medicine, Chicago, IL, ³Surgery, University of Chicago Medicine, Chicago, IL, ⁴Anesthesia, University of Chicago Medicine, Chicago, IL, ⁵Medicine, Massachusetts General Hospital, Boston, MA
*Purpose: The clinical impact of the components of a comprehensive geriatric assessment (CGA) on kidney transplant decision making in older adults has not been investigated.*Methods:…
2022 American Transplant Congress
Evaluation of a Change in Pharmacy Discharge Medication Education for Kidney Transplant Recipients
M. Borsh¹, M. Leick¹, A. Donovan², C. McAdam-Marx², M. Keck¹
¹Pharmacy, Nebraska Medicine, Omaha, NE, ²College of Pharmacy, University of Nebraska Medical Center, Omaha, NE
*Purpose: To evaluate if modification of pharmacy discharge education for kidney transplant recipients contributed to a decreased length of hospital stay (LOS) post-transplant.*Methods: This was…
2022 American Transplant Congress
Impact of COVID on Transplant Professionalism
A. Luxon¹, D. Brennan², F. Latif³, M. Flattery⁴, S. Aryal⁵
¹CareDx, South San Francisco, CA, ²Johns Hopkins Medical Institute, Baltimore, MD, ³Columbia University, New York, NY, ⁴Virginia Commonwealth University, Richmond, VA, ⁵Inova Fairfax Hospital, Falls Church, VA
*Purpose: Although, much has been written about COVID risk and immunization efficacy in transplant recipients, there is little data on the impact of COVID on…
2022 American Transplant Congress
Liver Transplant Recipient Gender and Race: Impact on Clinical Outcomes
M. M. French¹, R. Mangus¹, R. Holmes¹, A. Krause¹, J. Sumner¹, C. Kubal², B. Ekser³, P. Mihaylov⁴, J. Fridell⁵, A. Lutz⁶
¹Department of Surgery, Indiana University, Indianapolis, IN, ²Department of Surgery, Indiana University Hospital, Indianapolis, IN, ³Surgery, Indiana University - Transplant Surgery, Indianapolis, IN, ⁴Department of Surgery, Indiana Univ School of Medicine, Indianapolis, IN, ⁵Department of Surgery, Indiana University School of Medicine, Indianapolis, IN, ⁶Indiana University, Fishers, IN
*Purpose: Background. Health disparities are present in transplantation. This is a retrospective review of liver transplant (LT) recipients determining the impact of race/gender on early…
2022 American Transplant Congress
Direct Comparison of Clinical Outcomes with Belatacept-Based Regimens to Calcineurin Inhibitors Among DCD and/or High KDPI Kidney Transplant Recipients
A. Rizvi¹, M. Kueht², S. Hussain³, J. Fair², R. Ramirez⁴, A. Gamilla-Crudo⁵, M. Mujtaba⁵
¹Internal Medicine, Nephrology, University of Texas Medical Branch at Galveston, Galveston, TX, ²Surgery, University of Texas Medical Branch, Galveston, TX, ³University of Texas Medical Branch, Houston, TX, ⁴Surgery, University of Texas Medical Branch at Galveston, Galveston, TX, ⁵University of Texas Medical Branch, Galveston, TX
*Purpose: Belatacept, an inhibitor of the T-cell costimulatory pathway, can be used in recipients of Donation after Cardiac Death (DCD) and high Kidney Donor Profile…